BR112012013719A2 - uso de transferrina no tratamento de ß-talassemias - Google Patents

uso de transferrina no tratamento de ß-talassemias

Info

Publication number
BR112012013719A2
BR112012013719A2 BR112012013719A BR112012013719A BR112012013719A2 BR 112012013719 A2 BR112012013719 A2 BR 112012013719A2 BR 112012013719 A BR112012013719 A BR 112012013719A BR 112012013719 A BR112012013719 A BR 112012013719A BR 112012013719 A2 BR112012013719 A2 BR 112012013719A2
Authority
BR
Brazil
Prior art keywords
thalassemia
transferrin
treatment
reducing
iron
Prior art date
Application number
BR112012013719A
Other languages
English (en)
Inventor
Yelena Z Ginzburg
Original Assignee
New York Blood Ct Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Ct Inc filed Critical New York Blood Ct Inc
Publication of BR112012013719A2 publication Critical patent/BR112012013719A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

uso de transferrina no tratamento de <225>-talassemias. são divulgados aqui os métodos para o tratamento de doença, tais como doenças de sobrecarga de ferro, incluindo <225>-talassemia, compreendendo a administração de pelo menos um curso da transferrina e assim reduzindo o tamanho do baço no referido paciente e reduzindo a concentração de ferro nos tecidos e no sangue.
BR112012013719A 2009-12-08 2010-12-08 uso de transferrina no tratamento de ß-talassemias BR112012013719A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26777209P 2009-12-08 2009-12-08
PCT/US2010/059543 WO2011072059A1 (en) 2009-12-08 2010-12-08 Use of transferrin in treatment of beta-thalassemias

Publications (1)

Publication Number Publication Date
BR112012013719A2 true BR112012013719A2 (pt) 2016-03-15

Family

ID=43480422

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012013719A BR112012013719A2 (pt) 2009-12-08 2010-12-08 uso de transferrina no tratamento de ß-talassemias

Country Status (7)

Country Link
US (1) US20130143817A1 (pt)
EP (1) EP2509621A1 (pt)
AU (1) AU2010328167B2 (pt)
BR (1) BR112012013719A2 (pt)
CA (1) CA2782397A1 (pt)
IL (1) IL220241A0 (pt)
WO (1) WO2011072059A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160243201A1 (en) * 2013-11-05 2016-08-25 New York Blood Center, Inc. Methods and compositions for increasing hepcidin expession using modified iron binding/releasing transferrin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2395525A1 (en) * 1999-12-23 2001-06-28 Human Genome Sciences, Inc. Transferrin polynucleotides, polypeptides, and antibodies
US20050028229A1 (en) * 2003-04-14 2005-02-03 Mitchell Weiss Alpha-hemoglobin stabilizing protein transgenic mouse and methods of use thereof
WO2010147621A1 (en) * 2009-06-16 2010-12-23 The Trustees Of Columbia University In The City Of New York Methods for ameliorating adverse effects associated with transfusion of aged red blood cells

Also Published As

Publication number Publication date
AU2010328167A1 (en) 2012-06-07
WO2011072059A1 (en) 2011-06-16
CA2782397A1 (en) 2011-06-16
IL220241A0 (en) 2012-07-31
EP2509621A1 (en) 2012-10-17
AU2010328167B2 (en) 2014-05-08
US20130143817A1 (en) 2013-06-06

Similar Documents

Publication Publication Date Title
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
PH12015500297A1 (en) Adoptosis-inducing agents for the treatment of cancer and immune and automoimmune disease
NZ606825A (en) Methods and compositions for treating complement-associated disorders
BR112014016672A2 (pt) compostos de carbamato e sua preparação e uso
NO20075136L (no) Nye liposompreparater
SG158112A1 (en) Hepatocyte growth factor (hgf) binding proteins
MX337575B (es) Compuestos de sulfona y métodos para lafabricación y uso de éstos.
EA201791669A2 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
BR112012031727A2 (pt) conjugado de droga-anticorpo, composição farmacêutica, uso do conjugado de droga-anticorpo, método para induzir a eliminação celular ou inibir o crescimento e/ou a proliferação de uma célula tumoral, e, método de tratamento de doença.
EP2381957A4 (en) THERAPEUTIC MODULATION OF VAGINAL EPITHELIUM LIMITING LUBRICATION
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
BRPI0906181A2 (pt) &#34;método para tratamento de uma disfunção hiperproliferativa, composição farmacêutica, uso de uma combinação terapêutica na fabricação de um medicamento para o tratamento de câncer, artigo de fabricação para tratamento de uma disfunção hiperproliferativa, método para determinação de compostos a serem usados em combinação para o tratamento de câncer e método para determinação de uma combinação terapêutica a ser usada para o tratamento de câncer&#34;
BR112013004917A2 (pt) terapias de células tronco alogênicas sistêmicas para tratamento de doenças em animais.
UA108193C2 (uk) Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
ES2356883A1 (es) Composicion para el tratamiento del dolor y/o la inflamacion.
CR11731A (es) Composiciones y procedimientos para su preparación y uso
UY32882A (es) (heteroarilmetil) tiohidantoínas sustituidas
BR112012006252A2 (pt) &#34;formas cristalinas de abt-263 e solvatos para o uso no tratamento de doenças relacionadas á proteína bcl-2&#34;.
IN2015DN02729A (pt)
CY1118073T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης
EA200971107A1 (ru) Катехоламиновые производные, полезные для лечения болезни паркинсона
EP4124346A3 (en) Compositions and methods for treating diseases
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.